Lumida
/TOI
⌘K
Oncology Institute Inc

Oncology Institute Inc

TOI
$5.35USD+1.71%+0.09 today

MARKET CAP

534.9M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$2
$7

AI Summary

Stalk
Sell NowMedium

TOI is entrenched in a Stage 4 decline within a longer-term uptrend, having broken key multi-month support and triggering active bearish patterns. Price remains below the declining 9- and 21-EMAs with no sign of repair, confirming medium-term bearish control. Short-term conditions are unfavorable for longs, and any minor retracement toward the falling EMAs is likely resistance. Execution favors immediate participation in the breakdown continuation.

  • Q1 revenue $147M, up 41% YoY, fueled by pharmacy growth.
  • Specialty pharmacy revenue $87.5M, +77.6% YoY, diversifying income.
  • Earnings yield -0.97 indicates difficulty converting revenue to profit.
Full analysis →
Insider Trades8 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 14, 2026SellTOIYale PodnosChief Medical Officer46,904$4.16$534.9M-19.79%+130.60%$194.9K+0.00%Buy Now
Jun 8, 2026SellTOIYale PodnosChief Medical Officer23,451$5.38$534.9M-19.79%+130.60%$126.1K-8.29%10b5-1Buy Now
Jan 2, 2026SellTOIRobert Ross CarterChief Financial Officer247$3.56$534.9M-19.79%+130.60%$879.32-0.10%Buy Now
Mar 26, 2025BuyTOIRobert Ross CarterChief Financial Officer9,056$1.04$534.9M-19.79%+130.60%$9.4K+25.96%16bBuy Now
Mar 26, 2025BuyTOIJeremy CastleChief Operating Officer9,056$1.04$534.9M-19.79%+130.60%$9.4K+10.55%16bBuy Now
Mar 26, 2025BuyTOIYale PodnosChief Medical Officer9,056$1.04$534.9M-19.79%+130.60%$9.4K+12.15%16bBuy Now
Mar 26, 2025BuyTOIDaniel VirnichChief Executive Officer22,640$1.04$534.9M-19.79%+130.60%$23.6K+3.18%16bBuy Now
Dec 14, 2023BuyTOIMihir ShahChief Financial Officer100,000$1.27$534.9M-19.79%+130.60%$127.0K+18.00%Buy Now